Showing results (171-180 of 229) with videos related to

Sort By:
Pageof 23
Pneumologie (Stuttgart, Germany)|July 17, 2020
[48-Year-Old Triathlete with Severe COVID-19 Pneumonia: Successful and Safe Treatment with Oxygen and CPAP]P Stais, O Salloum, D Kühle, et al.
American Journal of Respiratory and Critical Care Medicine|August 3, 1999
Etiology of community-acquired pneumonia: impact of age, comorbidity, and severityM Ruiz, S Ewig, M A Marcos, et al.
Critical Care Medicine|August 31, 2000
Sampling methods for ventilator-associated pneumonia: validation using different histologic and microbiological referencesA Torres, N Fàbregas, S Ewig, et al.
The European Respiratory Journal|April 6, 2006
Mixed community-acquired pneumonia in hospitalised patientsA de Roux, S Ewig, E García, et al.
The Journal of Infectious Diseases|June 3, 1999
Phenotypically activated gammadelta T lymphocytes in the peripheral blood of patients with tuberculosisS I Behr-Perst, M E Munk, T Schaberg, et al.
Pneumologie (Stuttgart, Germany)|March 15, 2012
[International Standards of Tuberculosis Care (ISTC)--comments from the German point of view]S Castell, T Bauer, R Diel, et al.
The European Respiratory Journal|October 26, 2007
Procalcitonin predicts patients at low risk of death from community-acquired pneumonia across all CRB-65 classesS Krüger, S Ewig, R Marre, et al.
The European Respiratory Journal|September 7, 2010
How deadly is seasonal influenza-associated pneumonia? The German Competence Network for Community-Acquired PneumoniaH von Baum, B Schweiger, T Welte, et al.
The European Respiratory Journal|June 1, 2007
Sepsis severity predicts outcome in community-acquired pneumococcal pneumoniaB Schaaf, J Kruse, J Rupp, et al.
The European Respiratory Journal|August 13, 1998
Pulmonary complications in patients with haematological malignancies treated at a respiratory ICUS Ewig, A Torres, R Riquelme, et al.
Pageof 23